Novartis Investigative Site

South Bend, Indiana 46635

0 studies enrolling now · 4 studies all time

What they study most

Liver Disease, Neoplasms, Breast, Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Rheumatoid Arthritis

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) — Stopped early
• The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor. — Completed
• A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients — Completed